We are live on ! Find out more

1,619 hedge funds and large institutions have $126B invested in Merck in 2014 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 602 increasing their positions, 699 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 53

5% more funds holding in top 10

Funds holding in top 10: 140147 (+7)

0% more call options, than puts

Call options by funds: $950M | Put options by funds: $950M

0% less funds holding

Funds holding: 1,6211,619 (-2)

1% less capital invested

Capital invested by funds: $127B → $126B (-$978M)

1.04% less ownership

Funds ownership: 78.25%77.21% (-1%)

14% less repeat investments, than reductions

Existing positions increased: 602 | Existing positions reduced: 699

Holders
1,619
Holders Change
-2
Holders Change %
-0.12%
% of All Funds
46.95%
Holding in Top 10
147
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+5%
% of All Funds
4.26%
New
65
Increased
602
Reduced
699
Closed
53
Calls
$950M
Puts
$950M
Net Calls
+$352K
Net Calls Change
-$100M
Name Holding Trade Value Shares
Change
Change in
Stake
FC
1101
Forte Capital
New York
$1.16M +$1.15M +20,537 New
OPCM
1102
Osborne Partners Capital Management
California
$1.16M -$68.9K -1,227 -6%
PFA
1103
Pure Financial Advisors
California
$1.16M -$11.6K -207 -1%
NAM
1104
NorthCoast Asset Management
Connecticut
$1.16M
IAA
1105
Ironsides Asset Advisors
North Carolina
$1.16M +$730 +13 +0.1%
Harris Associates
1106
Harris Associates
Illinois
$1.16M
PAI
1107
Pittenger & Anderson Inc
Nebraska
$1.15M +$20.6K +367 +2%
NL
1108
NWAM LLC
Washington
$1.15M -$1.29M -22,961 -53%
NERM
1109
New England Research & Management
Illinois
$1.15M -$53K -943 -4%
MPA
1110
Marvin & Palmer Associates
Delaware
$1.14M -$356K -6,343 -24%
TWA
1111
TCI Wealth Advisors
Arizona
$1.13M +$11.3K +201 +1%
GT
1112
Greenleaf Trust
Michigan
$1.12M +$3.93K +70 +0.4%
MBT
1113
Monroe Bank & Trust
Michigan
$1.12M -$311K -5,545 -22%
BFIM
1114
Beese Fulmer Investment Management
Ohio
$1.12M +$94.2K +1,677 +9%
ARMT
1115
Amica Retiree Medical Trust
Rhode Island
$1.12M
GF
1116
Gerstein Fisher
New York
$1.11M +$30.8K +548 +3%
PWM
1117
Perigon Wealth Management
California
$1.11M -$387K -6,896 -26%
CBT
1118
Central Bank & Trust
Kentucky
$1.11M +$71.3K +1,269 +7%
BRWM
1119
B. Riley Wealth Management
Tennessee
$1.11M -$2.42K -43 -0.2%
PTC
1120
Philadelphia Trust Company
Pennsylvania
$1.11M -$340K -6,047 -24%
ACA
1121
Anchor Capital Advisors
Massachusetts
$1.1M -$15.4K -275 -1%
CIC
1122
Carnegie Investment Counsel
Ohio
$1.1M +$472K +8,406 +76%
LIM
1123
Leavell Investment Management
Alabama
$1.1M +$118K +2,096 +12%
NCM
1124
Noesis Capital Mangement
Florida
$1.1M +$381K +6,780 +54%
CG
1125
Colony Group
Massachusetts
$1.1M +$872K +15,530 +405%

MRK Hedge Fund Activity: Q3 2014 in Review

1,619 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2014, worth a combined $126B — down 0.77% from $127B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new MRK positions and 53 closed out — a net gain of 12 holders — while 602 added to existing stakes and 699 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $434M. The largest seller was Norges Bank, cutting an estimated $1.3B.

  • 1,619 institutional investors held Merck (MRK) as of Q3 2014, down from 1,621 in Q2 2014.
  • Funds reported $126B of Merck stock for Q3 2014, down 0.77% quarter-over-quarter.
  • 65 funds opened new Merck positions in Q3 2014 and 53 closed out, a net change of +12 holders.
  • The largest Merck buyer in Q3 2014 was JP Morgan Chase, an estimated $434M added.
  • The largest Merck seller in Q3 2014 was Norges Bank, an estimated $1.3B sold.

Based on aggregated 13F filings for Q3 2014.